Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily

By Lewis D. F. V.   Dickins M.   Weaver R. J.   Eddershaw P. J.   Goldfarb P. S.   Tarbit M. H.  

Xenobiotica, Vol. 28, Iss. 3, 1998-03 ,pp. : 235-268

Informa Healthcare

Access to resources Recommend Favorite

Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population

By Hanioka N.   Hanioka N.   Tsuneto Y.   Saito Y.   Sumada T.   Maekawa K.   Saito K.   Sawada J.   Narimatsu S.  

Xenobiotica, Vol. 37, Iss. 4, 2007-10 ,pp. : 342-355

Informa Healthcare

Access to resources Recommend Favorite

Effects of CYP2C19 polymorphism on the pharmacokinetics of lansoprazole and its main metabolites in healthy Chinese subjects

By Zhang Dan   Wang Xiaolin   Yang Man   Wang Guocai   Liu Huichen  

Xenobiotica, Vol. 41, Iss. 6, 2011-06 ,pp. : 511-517

Informa Healthcare

Access to resources Recommend Favorite

Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes

By Tu J.-H.   Hu D.-L.   Dai L.-L.   Sun Y.   Fan L.   Zhang M.   Tan Z.-R.   Chen Y.   Li Z.   Zhou H.-H.  

Xenobiotica, Vol. 40, Iss. 6, 2010-06 ,pp. : 393-399

Informa Healthcare

Access to resources Recommend Favorite

Lipophilicity Relationships in Inhibitors of CYP2C9 and CYP2C19 Enzymes

By Lewis David F.V.   Lake Brian G.   Ito Yuko   Dickins Maurice  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 4, 2006-08 ,pp. : 385-389

Informa Healthcare

Access to resources Recommend Favorite